Home › Epilessia › Massachusetts › Boston
Studi clinici su Epilessia a Boston, MA
19 studi su Epilessia cercano partecipanti presso sedi a Boston e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
In reclutamentoFase 2
- Boston Children's Hospital, Boston
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
In reclutamentoStudio osservazionale
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
In reclutamentoFase 1/2
- Brigham and Women's Hospital, Boston
Diagnosing Epilepsy To EffeCT Change
In reclutamento
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
In reclutamentoFase 1/2
- Massachusetts General Hospital, Boston
Subcortical Arousal in Perceptual Awareness
In reclutamento
- Massachusetts General Hospital, Boston
Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies
In reclutamentoFase 1
- Boston Children's Hospital, Boston
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
In reclutamentoFase 3
- Beth Israel Deaconess Medical Center, Boston
Computational Neuroscience of Language Processing in the Human Brain
In reclutamento
- Massachusetts General Hospital, Boston
PET/MRI/EEG Imaging Study in Epilepsy
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Athinoula A. Martinos Center, Charlestown · a 1 mi di distanza
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
In reclutamentoFase 4Volontari sani benvenuti
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
A Multicenter Pediatric Deep Brain Stimulation Registry
In reclutamentoStudio osservazionale
- Boston Children's Hospital, Boston
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
In reclutamentoStudio osservazionale
- Boston Children's Hospital, Boston
Infrared Photobiomodulation in Humans With Epilepsy
In reclutamento
- BIDMC, Boston
Genetics of Epilepsy and Related Disorders
In reclutamentoStudio osservazionale
- Boston Children's Hospital, Boston
Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)
In reclutamentoStudio osservazionale
- Boston Children's Hospital, Boston
Registry and Natural History of Epilepsy-Dyskinesia Syndromes
In reclutamentoStudio osservazionale
- Boston Children's Hospital, Boston
Epilepsy Learning Healthcare System (ELHS)
In reclutamentoStudio osservazionale
- Partners - Massachusetts General Hospital Epilepsy Service (MGH)/ Partners - Brigham and Women's (BWH), Boston
- Brigham & Women's Hospital, Boston
Human Epilepsy Genetics--Neuronal Migration Disorders Study
In reclutamentoStudio osservazionale
- Boston Children's Hospital, Walsh Laboratory, Boston
Studi su Epilessia in altre città
- Houston, TX16 studi
- New York City, NY13 studi
- Washington, DC12 studi
- Philadelphia, PA11 studi
- Cleveland, OH9 studi
- Phoenix, AZ9 studi
- Durham, NC8 studi
- Rochester, MN8 studi
- Birmingham, AL7 studi
- Mountain View, CA7 studi
- St. Louis, MO7 studi
- Miami, FL7 studi
Altri studi a Boston
- Cancro al seno111 studi
- Cancro del polmone non a piccole cellule90 studi
- Cancro (tutti i tipi)86 studi
- Cancro colorettale63 studi
- Cancro metastatico63 studi
- Cancro ai polmoni62 studi
- Cancro ovarico61 studi
- Cancro alla prostata59 studi
- Depressione52 studi
- Cancro dell'endometrio50 studi
- Insufficienza cardiaca44 studi
- Leucemia mieloide acuta44 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.